On this episode of Stock Movers:
- BioMarin (BMRN) shares rise after the company agreed to buy Amicus Therapeutics Inc. for about $4.8 billion, helping the biotech company expand its portfolio of treatments for rare diseases.
- FedEx (FDX) shares fall the most intraday since June 25, as the shipping firm upgraded FY targets, but to a lower magnitude than the 2Q earnings beat as it suffers from a string of cost headwinds including the grounding of its MD-11 planes.
- Nike (NKE) shares sink after the company warned that sales will decline this quarter amid persistent weakness in China and at its Converse brand. The world’s largest sportswear company expects revenue to be down in the low-single digits in the three months that started Dec. 1, a surprising turn after two straight periods of growth.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Shares of Nike (NKE) fell as much as 10 percent in premarket trading as the sportswear retailer’s third-quarter guidance disappointed investors, with its turnaround hampered by weak sales in China and the Converse brand. It expects third-quarter sales to be down low-single digits, and gross margins to shrink by roughly 2 percentage points due to tariffs. North America business — a bright spot for fiscal 2Q — is expected to grow more slowly in the third quarter as product liquidation will no longer provide a big sales boost.
- Shares of FedEx (FDX) edged lower in the early session as the shipping firm upgraded FY targets, but to a lower magnitude than the 2Q earnings beat as it suffers from a string of cost headwinds including the grounding of its MD-11 planes. Analysts are mostly positive on 2Q results that are boosted by peak season demand, cost reductions and customer wins in B2B health care. The non-core freight division that’s scheduled to be spun off remains under pressure.
- Shares of Oracle (ORCL) rallied ahead of the US market open as TikTok’s long-delayed plan to separate from Chinese parent ByteDance Ltd. was put in motion Thursday when the video sharing sensation said it’s being bought by a group of buyers, led by Oracle. TikTok Chief Executive Officer Shou Chew told employees that the company and ByteDance signed binding agreements to create a US joint venture majority-owned by American investors, according to an internal memo reviewed by Bloomberg. Chew wrote that he was “pleased to share some great news” and said agreements with Oracle, Silver Lake Management and MGX have been signed. The deal is expected to close on Jan. 22, 2026, though Chew added that “there’s more work to be done” before then. Chinese regulators have yet to say whether they’ll approve the transaction.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

- Shares of Nike (NKE) fell as much as 10 percent in premarket trading as the sportswear retailer’s third-quarter guidance disappointed investors, with its turnaround hampered by weak sales in China and the Converse brand. It expects third-quarter sales to be down low-single digits, and gross margins to shrink by roughly 2 percentage points due to tariffs. North America business — a bright spot for fiscal 2Q — is expected to grow more slowly in the third quarter as product liquidation will no longer provide a big sales boost.

- Shares of Oracle (ORCL) rallied ahead of the US market open as TikTok’s long-delayed plan to separate from Chinese parent ByteDance Ltd. was put in motion Thursday when the video sharing sensation said it’s being bought by a group of buyers, led by Oracle. TikTok Chief Executive Officer Shou Chew told employees that the company and ByteDance signed binding agreements to create a US joint venture majority-owned by American investors, according to an internal memo reviewed by Bloomberg. Chew wrote that he was “pleased to share some great news” and said agreements with Oracle, Silver Lake Management and MGX have been signed. The deal is expected to close on Jan. 22, 2026, though Chew added that “there’s more work to be done” before then. Chinese regulators have yet to say whether they’ll approve the transaction.

- Shares of FedEx (FDX) edged lower in the early session as the shipping firm upgraded FY targets, but to a lower magnitude than the 2Q earnings beat as it suffers from a string of cost headwinds including the grounding of its MD-11 planes. Analysts are mostly positive on 2Q results that are boosted by peak season demand, cost reductions and customer wins in B2B health care. The non-core freight division that’s scheduled to be spun off remains under pressure.

See omnystudio.com/listener for privacy information.

On This episode of Stock Movers:
- WH Smith is under investigation by the UK’s Financial Conduct Authority over the accounting error in its North American business that triggered a stock slump and the resignation of its chief executive officer.
- BBVA SA said it will carry out its largest share buyback ever as it seeks to draw a line under its failed bid for Banco Sabadell.
- Ipsen shares drop as much as 3.8%, the worst performance in the Stoxx 600 Health Care Index on Friday morning, after the company said a mid-stage trial evaluating its experimental oral drug for an ultra-rare bone disease did not meet its primary endpoint.

See omnystudio.com/listener for privacy information.

On This episode of Stock Movers:
- Renault has regained its investment-grade status at S&P Global Ratings. UBS rates Arcadis and Rieter neutral. On Tradegate, Rolls-Royce and Ads-Tec Energy are among the most active industrials stocks before European markets open, gaining 1.2% and falling 8.2% respectively.
- European sportswear stocks could be active on Friday after Nike warned sales will decline this quarter due to weakness in China and its Converse brand
- WH Smith is under investigation by the UK’s Financial Conduct Authority over the accounting error in its North American business that triggered a stock slump and the resignation of its chief executive officer.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Micron (MU) kicked off its biggest single-day stock gain in more than eight months after delivering an upbeat forecast for the current quarter, signaling that surging demand and supply shortages are allowing the memory-chip maker to charge more for products.
- Nike (NKE) posted more weakness in China and its Converse brand, sending shares down and offsetting higher-than-expected revenue in the latest quarter. Direct-to-consumer sales missed expectations, while Converse plunged 30% in the fiscal second quarter ended Nov. 30. Revenue rose 1% to $12.4 billion, above the average of analyst estimates.
- FedEx Corp. (FDX) raised the low end of its full-year profit and sales outlook, signaling the company’s efforts to slash costs and streamline its delivery networks are bearing fruit as demand improvesSebastian Escobar

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

- Cannabis stocks like Tilray (TLRY) and Canopy (CGC) fell Thursday after President Donald Trump signed an executive order to reschedule marijuana as a lower-class drug. Trump's order reclassifies marijuana as a Schedule III drug from Schedule I, but doesn't permit legalized recreational sales. Other Schedule I substances include highly addictive drugs with no accepted medical use, such as heroin, while Schedule III substances are considered to have lower potential for abuse.

- Birkenstock (BIRK) shares drop after the company predicted a slower pace of sales growth in the coming year as its sandals and clogs contend with the impact of a weaker US dollar and tariffs.

- Shares of Lululemon (LULU) jumped after activist investor Elliott Investment Management has built a stake of more than $1 billion in Lululemon. Elliott has been working with retail executive Jane Nielsen, who is viewed as a potential CEO candidate, as the company searches for a replacement for current CEO Calvin McDonald.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Cannabis stocks like Tilray (TLRY) and Canopy (CGC) fell Thursday after President Donald Trump signed an executive order to reschedule marijuana as a lower-class drug. Trump's order reclassifies marijuana as a Schedule III drug from Schedule I, but doesn't permit legalized recreational sales. Other Schedule I substances include highly addictive drugs with no accepted medical use, such as heroin, while Schedule III substances are considered to have lower potential for abuse.
- Shares of Micron Technology (MU) the largest US maker of computer memory chips, rose by the most in eight months after the company gave an upbeat forecast for the current quarter, signaling that surging demand and supply shortages are allowing the company to charge more for products.
- Shares of Lululemon (LULU) jumped after activist investor Elliott Investment Management has built a stake of more than $1 billion in Lululemon. Elliott has been working with retail executive Jane Nielsen, who is viewed as a potential CEO candidate, as the company searches for a replacement for current CEO Calvin McDonald.

See omnystudio.com/listener for privacy information.